Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research and Development Expenses, Net (Tables)

v3.8.0.1
Research and Development Expenses, Net (Tables)
 12 Months Ended
Dec. 31, 2017
Research and Development Expenses, Net [Abstract]  
Schedule of research and development expenses

 

    Year ended December 31  
    2017     2016     2015  
                   
Salaries and related expenses   $ 144,250     $ 136,578     $ 166,849  
Stock-based compensation     22,883       48,056       -  
Professional fees     31,690       56,377       53,750  
Laboratory and materials     184,073       124,748       50,858  
Patent expenses     62,888       24,956       51,846  
Liability for minimum royalties expenses (*)     238,000       50,000       35,000  
Depreciation     24,083       20,526       11,369  
Travel expenses     6,512       19,419       -  
Insurance and other expenses     6,148       3,293       4,351  
      720,527       483,953       374,023  
Less: Grants from the OCS and others (**)     -       (166,046 )     -  
    $ 720,527     $ 317,907     $ 374,023  

 

(*) See Note 9B.

 

(**) See Note 9A and 9D.